It remained significantly elevated at the end of the low-dose insulin infusion step (SSNEFA 1 ) and at the borderline significance level at the end of the high-dose insulin infusion step (SSNEFA 2 ) of the euglycemic clamp ( Table 2 ).
← all excerpts
Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes.
1
—
—